Diapharma SRL
Diapharma reported total assets of 600,343 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026).
The score of Diapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +57 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Diapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 51,639 € | ||||
| Equity | 357,269 € | ||||
| Cash | 397,365 € | ||||
| EBITDA | 105,394 € | ||||
| Total assets | 600,343 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 16 Aug 2024
- Year ended 31 Dec 2022filed on 22 Jul 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Diapharma's financial analysis
- Solvency59.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Diapharma
Diapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.698.006
- VAT number
- BE0474698006
- Peppol
- Registered · 0208:0474698006 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Apr 2001
- Registered office
- 3010 Leuven
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Diapharma (SRL) has been based in Leuven since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 51,639 € and equity of 357,269 €; its revenue is not published. Its solvency stands at 59.5%, above the median of its sector (44.2%).
Companies similar to Diapharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Frenkel DU Page Retail sale of pharmaceutical products Ixelles · balance sheet 600,607 €
- Apotheek DE Witte Retail sale of pharmaceutical products Asse · balance sheet 600,646 €
- DE Bosmolens Retail sale of pharmaceutical products Izegem · balance sheet 599,551 €
- Etis Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 599,365 €
- Dubart - Lamalle Retail sale of pharmaceutical products Chaudfontaine · balance sheet 599,335 €
- Luxpharma Retail sale of pharmaceutical products Bouillon · balance sheet 602,345 €
- Jacky-Mo Retail sale of pharmaceutical products Schaerbeek · balance sheet 597,743 €
- LO-Pharma Retail sale of pharmaceutical products Lubbeek · balance sheet 597,566 €
Frequently asked questions about Diapharma
What is the revenue of Diapharma?
Diapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Diapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0474698006 for Diapharma, if the company is VAT-registered. Its company number (CBE) is 0474.698.006.
Where is the registered office of Diapharma?
According to the CBE register, the registered office of Diapharma is in 3010 Leuven.
What is the equity of Diapharma?
At the close of the 2025 financial year, the equity of Diapharma amounts to 357,269 €, a solvency of 59.5% of total assets.
Who manages Diapharma?
The register lists 1 active mandates at Diapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Diapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →